Personal information

No personal information available

Activities

Collapse all

Employment (3)

Saha Institute of Nuclear Physics: Kolkata, West Bengal, IN

2019-12-16 to present | Associate Prof E (Biophysics & Structural Genomics)
Employment
Source: Self-asserted source
Subhabrata Majumder

AstraZeneca Medimmune: Gaithersburg, MD, US

2019-07-04 to 2019-12-04 | Scientist I (Late Stage Formulation Development)
Employment
Source: Self-asserted source
Subhabrata Majumder

Pfizer: St Louis, MO, US

2016-04-18 to 2019-07-01 | Postdoctoral Scientist (Worldwide Research Development)
Employment
Source: Self-asserted source
Subhabrata Majumder

Works (18)

Profiling Enzyme Activity of <scp>l</scp>-Asparaginase II by NMR-Based Methyl Fingerprinting at Natural Abundance

Journal of the American Chemical Society
2023-05-17 | Journal article | Author
DOI: 10.1021/jacs.3c02154
Part of ISSN: 0002-7863
Part of ISSN: 1520-5126
Contributors: Rachayita Nag; Srishti Joshi; Anurag Rathore; Subhabrata Majumder
Source: Self-asserted source
Subhabrata Majumder
grade
Preferred source (of 2)‎

Rewiring of Drug Metabolism and Its Cross‐talk with Metabolic Reprogramming in Cancer

Drug Metabolism Handbook
2022-12-08 | Other
DOI: 10.1002/9781119851042.ch27
ISBN: 9781119851011
ISBN: 9781119851042
Contributors: SUBHABRATA MAJUMDER; Soumen Kanti Manna
Source: Self-asserted source
Subhabrata Majumder

Utility of High Resolution 2D NMR Fingerprinting in Assessing Viscosity of Therapeutic Monoclonal Antibodies

Pharmaceutical Research
2022-03 | Journal article
DOI: 10.1007/s11095-022-03200-6
Part of ISSN: 0724-8741
Part of ISSN: 1573-904X
Source: Self-asserted source
Subhabrata Majumder

Utility of High Resolution NMR Methods to Probe the Impact of Chemical Modifications on Higher Order Structure of Monoclonal Antibodies in Relation to Antigen Binding

Pharmaceutical Research
2019-09 | Journal article
DOI: 10.1007/s11095-019-2652-1
Part of ISSN: 0724-8741
Part of ISSN: 1573-904X
Source: Self-asserted source
Subhabrata Majumder

Impact of Buffers on Colloidal Property and Aggregation Propensities of a Bispecific Antibody.

Journal of pharmaceutical sciences
2018-11-02 | Journal article
DOI: 10.1016/j.xphs.2018.10.048
PMID: 30391414
Source: Self-asserted source
Subhabrata Majumder

Probing Conformational Diversity of Fc Domains in Aggregation-Prone Monoclonal Antibodies.

Pharmaceutical research
2018-09-25 | Journal article
DOI: 10.1007/s11095-018-2500-8
PMID: 30255351
Source: Self-asserted source
Subhabrata Majumder

Ribosome Mediated Quinary Interactions Modulate In-Cell Protein Activities.

Biochemistry
2017-08-03 | Journal article
DOI: 10.1021/acs.biochem.7b00613
PMID: 28715177
PMC: PMC5956540
Source: Self-asserted source
Subhabrata Majumder

Total Cellular RNA Modulates Protein Activity.

Biochemistry
2016-08-03 | Journal article
DOI: 10.1021/acs.biochem.6b00330
PMID: 27456029
PMC: PMC5645783
Source: Self-asserted source
Subhabrata Majumder

Design of a MCoTI-Based Cyclotide with Angiotensin (1-7)-Like Activity.

Molecules (Basel, Switzerland)
2016-01-26 | Journal article
DOI: 10.3390/molecules21020152
PMID: 26821010
PMC: PMC4795166
Source: Self-asserted source
Subhabrata Majumder

Recombinant Expression and Phenotypic Screening of a Bioactive Cyclotide Against α-Synuclein-Induced Cytotoxicity in Baker's Yeast.

Angewandte Chemie (International ed. in English)
2015-06-10 | Journal article
DOI: 10.1002/anie.201501186
PMID: 26096948
PMC: PMC4545262
Source: Self-asserted source
Subhabrata Majumder

Probing protein quinary interactions by in-cell nuclear magnetic resonance spectroscopy.

Biochemistry
2015-04-27 | Journal article
DOI: 10.1021/acs.biochem.5b00036
PMID: 25894651
PMC: PMC4447238
Source: Self-asserted source
Subhabrata Majumder

Caught in action: selecting peptide aptamers against intrinsically disordered proteins in live cells.

Scientific reports
2015-03-24 | Journal article
DOI: 10.1038/srep09402
PMID: 25801767
PMC: PMC4371151
Source: Self-asserted source
Subhabrata Majumder

Using singular value decomposition to characterize protein-protein interactions by in-cell NMR spectroscopy.

Chembiochem : a European journal of chemical biology
2014-04-01 | Journal article
DOI: 10.1002/cbic.201400030
PMID: 24692227
PMC: PMC4041589
Source: Self-asserted source
Subhabrata Majumder

In vivo activation of the p53 tumor suppressor pathway by an engineered cyclotide.

Journal of the American Chemical Society
2013-07-25 | Journal article
DOI: 10.1021/ja405108p
PMID: 23848581
PMC: PMC3767463
Source: Self-asserted source
Subhabrata Majumder

Expression of fluorescent cyclotides using protein trans-splicing for easy monitoring of cyclotide-protein interactions.

Angewandte Chemie (International ed. in English)
2013-01-15 | Journal article
DOI: 10.1002/anie.201209219
PMID: 23322720
PMC: PMC3767473
Source: Self-asserted source
Subhabrata Majumder

Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity.

Journal of medicinal chemistry
2012-11-27 | Journal article
DOI: 10.1021/jm301468k
PMID: 23151033
PMC: PMC3521869
Source: Self-asserted source
Subhabrata Majumder

Efficient one-pot cyclization/folding of Rhesus θ-defensin-1 (RTD-1).

Bioorganic & medicinal chemistry letters
2012-03-02 | Journal article
DOI: 10.1016/j.bmcl.2012.02.080
PMID: 22425570
PMC: PMC3590006
Source: Self-asserted source
Subhabrata Majumder

Recombinant production of rhesus θ-defensin-1 (RTD-1) using a bacterial expression system.

Molecular bioSystems
2012-02-10 | Journal article
DOI: 10.1039/c2mb05451e
PMID: 22327102
PMC: PMC3330704
Source: Self-asserted source
Subhabrata Majumder

Peer review (1 review for 1 publication/grant)

Review activity for Communications biology. (1)
How many people are using ORCID?